OTC : CHMP

Champion Industries Inc — News

$0.02 USD

$0 (0.0%)

Volume
51
Average Volume
44
Market Capitalization
$1.13K
P/E Ratio
0.00
Dividend Yield
0.00%
Price Target
Year High
$0.02
Year Low
$0.00
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$0.76
Source Headline
AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Severe Alopecia Areata

AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQÂ) for the Treatment of Adults and Adolescents with Severe Alopecia Areata

gurufocus.com - 2026-06-29 04:00:00

Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis

Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positi

gurufocus.com - 2026-06-26 08:00:00

Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with chronic lymphocytic leukemia (CLL) across all lines of therapy

Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with chronic lymphocytic leukemia (CLL) acro

gurufocus.com - 2026-06-26 08:00:00

Get CHMP Insider Trade Alerts

CHMP Price Target Summary

Last Month

0 analysts

Last Quarter

0 analysts

Last Year

0 analysts

All Time

0 analysts

CHMP Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade